FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE
FDA is a Ligand Of Interest in 4MOM designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4MOM_FDA_D_801 | 89% | 7% | 0.091 | 0.969 | 1.57 | 3.16 | 8 | 22 | 2 | 0 | 100% | 1 |
4MOM_FDA_B_702 | 86% | 4% | 0.099 | 0.967 | 1.7 | 3.99 | 13 | 19 | 1 | 0 | 100% | 1 |
4MOM_FDA_A_801 | 85% | 6% | 0.102 | 0.966 | 1.6 | 3.35 | 8 | 21 | 3 | 0 | 100% | 1 |
4MOM_FDA_C_801 | 77% | 4% | 0.109 | 0.948 | 1.73 | 3.73 | 11 | 24 | 1 | 0 | 100% | 1 |
4MOR_FDA_D_801 | 98% | 7% | 0.057 | 0.975 | 1.79 | 2.92 | 10 | 22 | 2 | 0 | 100% | 1 |
4MOQ_FDA_A_801 | 97% | 5% | 0.063 | 0.98 | 2.05 | 3.18 | 11 | 17 | 1 | 0 | 100% | 1 |
4MOF_FDA_A_801 | 96% | 10% | 0.071 | 0.982 | 1.64 | 2.7 | 11 | 13 | 1 | 0 | 100% | 1 |
4MOO_FDA_A_801 | 96% | 9% | 0.071 | 0.981 | 1.66 | 2.85 | 12 | 17 | 2 | 0 | 100% | 1 |
4MOS_FDA_A_801 | 95% | 6% | 0.075 | 0.98 | 1.94 | 3.19 | 14 | 16 | 5 | 0 | 100% | 1 |
3TSH_FDA_A_601 | 100% | 38% | 0.04 | 0.992 | 1.03 | 1.38 | 3 | 6 | 3 | 0 | 100% | 1 |
7AA2_FDA_A_701 | 100% | 60% | 0.043 | 0.986 | 0.69 | 0.83 | - | 1 | 3 | 0 | 100% | 1 |
6ZE6_FDA_A_701 | 100% | 60% | 0.044 | 0.984 | 0.72 | 0.8 | - | 1 | 3 | 0 | 100% | 1 |
4U2S_FDA_A_605 | 99% | 14% | 0.064 | 0.997 | 1.76 | 2.08 | 9 | 9 | 5 | 0 | 100% | 1 |
6ZE2_FDA_B_701 | 99% | 60% | 0.048 | 0.979 | 0.71 | 0.83 | - | 1 | 3 | 0 | 100% | 1 |